The U.S. Food and Drug Administration is warning consumers not to use off-brand versions of the popular weight-loss drugs.
FILE - This Tuesday, April 3, 2018 file photo shows a closeup of a beam scale in New York. The Food and Drug Administration is warning consumers, Thursday, June 1, 2023, not to use off-brand versions of the popular weight-loss drugs Ozempic and Wegovy sold online because they might not contain the same ingredients as the prescription products and may not be safe or effective.
The trouble is that those versions, often sold online, contain a version of semaglutide that is used in lab research and has not been approved for use in people. Sales of semaglutide products have soared in the past few years after the drug was shown to spur fast and significant weight loss. The drugs manufactured by Novo Nordisk include brands Ozempic and Rybelsus, used to treat diabetes, and Wegovy, approved to treat obesity.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA warns consumers not to use off-brand versions of Ozempic, WegovyConsumers should only use semaglutide prescribed by a health care provider and filled by a licensed pharmacy, FDA said.
Lire la suite »
FDA warns consumers not to use off-brand versions of Ozempic, WegovySales of semaglutide products have soared in the past few years after the drug was shown to spur fast and significant weight loss.
Lire la suite »
Ozempic, Wegovy and pregnancy risk: What you need to know about the issueStudies show that animals given semaglutide experience higher rates of miscarriage, birth defects and small fetal size — prompting FDA calls for investigations into Ozempic and Wegovy. Novo Nordisk weighs in.
Lire la suite »
Ozempic: Weight loss, side effects and potential to treat addictionThe drugs Ozempic and Wegovy can help people who are obese or overweight to quickly lose weight, but some are concerned they may cause hair loss or a gaunt appearance, dubbed 'Ozempic face'. What's the science behind the treatments?
Lire la suite »
CDC says sick leave can prevent food poisoning — but few food workers get paid time offFood contamination by sick workers contributed to approximately 40% of infectious-disease outbreaks, a new report finds.
Lire la suite »
Ozempic Craze Has Spawned a Sketchy Black Market, FDA WarnsThe FDA has received adverse event reports from people using compounded semaglutide, which might not contain the same version of the popular obesity drug.
Lire la suite »